Blood vessel regeneration could help reverse MI tissue damage

A new study done by researchers in the United Kingdom explores how manipulating the hormone leptin to grow new blood vessels could help regenerate tissues in heart failure patients.

Leptin, produced by fat cells, helps regulate energy balance in the body by decreasing an individual’s appetite. The full study was published in Scientific Reports. In the future, these findings could help develop an alternative treatment to coronary artery bypass surgery for heart patients.

The study was led by Paolo Madeddu, a professor of experimental cardiovascular medicine at the University of Bristol.

Results showed that the cells surrounding blood vessels, called pericytes, produced 40 times more leptin when they were exposed to low levels of oxygen, helping them to build more blood vessels and increase blood flow and oxygen.

"This new discovery could have important implications for the treatment of heart attacks, which is when a main coronary artery gets blocked, but also cancer," Madeddu said in a statement. "These results reveal a new signaling mechanism that may have a far-reaching and significant impact on cardiovascular regenerative medicine. Increasing leptin in pericytes in a damaged heart might help it to heal faster, whereas blocking the production of leptin in cancerous pericytes might starve the tumor of nutrients and force it to shrink."

Katherine Davis,

Senior Writer

As a Senior Writer for TriMed Media Group, Katherine primarily focuses on producing news stories, Q&As and features for Cardiovascular Business. She reports on several facets of the cardiology industry, including emerging technology, new clinical trials and findings, and quality initiatives among providers. She is based out of TriMed's Chicago office and holds a bachelor's degree in journalism from Columbia College Chicago. Her work has appeared in Modern Healthcare, Crain's Chicago Business and The Detroit News. She joined TriMed in 2016.

Around the web

Several key trends were evident at the Radiological Society of North America 2024 meeting, including new CT and MR technology and evolving adoption of artificial intelligence.

Ron Blankstein, MD, professor of radiology, Harvard Medical School, explains the use of artificial intelligence to detect heart disease in non-cardiac CT exams.

Eleven medical societies have signed on to a consensus statement aimed at standardizing imaging for suspected cardiovascular infections.